Scientific Opinion on the substantiation of health claims related to fructooligosaccharides (FOS) from sucrose and decreasing potentially pathogenic gastro intestinal microorganisms (ID 774), changes in short chain fatty acid (SCFA) production and pH in the gastro-intestinal tract (ID 775), changes in bowel function (ID 775, 778), reduction of gastro intestinal discomfort (ID 775, 778), increase in calcium and/or magnesium absorption leading to an increase in magnesium and/or calcium retention (ID 776, 777), maintenance of normal blood LDL cholesterol concentrations (ID 805) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 805) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Meta data
Keywords
Fructooligosaccharides, pathogenic microorganisms, bowel function, gastro-intestinal comfort, calcium absorption, magnesium absorption, LDL-cholesterol, triglycerides, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-1561
EFSA-Q-2008-1562
EFSA-Q-2008-1563
EFSA-Q-2008-1564
EFSA-Q-2008-1565
EFSA-Q-2008-1592
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Contact
Abstract
No abstract available
© European Food Safety Authority, 2011